Abstract
The benign form of ocular adnexal lymphoproliferative disorder (OAL) is reactive lymphoid hyperplasia (RLH). About 16% of all OAL is reactive and benign, based on immunohistopathological staining and molecular studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Coupland SE, Krause L, Delecluse HJ, Anagnostopoulos I, Foss HD, Hummel M, Bornfeld N, Lee WR, Stein H. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology. 1998;105(8):1430–41.
Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol. 2010;128(5):577–84.
Mannami T, Yoshino T, Oshima K, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol. 2001;14(7):641–9.
Stacy RC, Jakobiec FA, Schoenfield L, Singh AD. Unifocal and multifocal reactive lymphoid hyperplasia vs follicular lymphoma of the ocular adnexa. Am J Ophthalmol. 2010;150(3):412–26.
Verdijk RM. Lymphoproliferative tumors of the ocular adnexa. Asia Pac J Ophthalmol (Phila). 2017;6(2):132–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Parulan, M.A. et al. (2019). Reactive Lymphoid Hyperplasia. In: Amrith, S., Sundar, G., Young, S. (eds) Ocular Adnexal Lesions. Springer, Singapore. https://doi.org/10.1007/978-981-13-3798-7_34
Download citation
DOI: https://doi.org/10.1007/978-981-13-3798-7_34
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3797-0
Online ISBN: 978-981-13-3798-7
eBook Packages: MedicineMedicine (R0)